Nuvectis Pharma, Inc. NVCT Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Nuvectis Pharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Nuvectis Pharma, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvectis Pharma, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvectis Pharma, Inc.'s change in AP?
- Nuvectis Pharma, Inc. (NVCT) reported change in AP of -$1.58M in Q1 2026.
- How has Nuvectis Pharma, Inc.'s change in AP changed year-over-year?
- Nuvectis Pharma, Inc.'s change in AP decreased by 419.6% year-over-year, from $494K to -$1.58M.
- What is the long-term trend for Nuvectis Pharma, Inc.'s change in AP?
- Over 2 years (2021 to 2025), Nuvectis Pharma, Inc.'s change in AP has grown at a 57.7% compound annual growth rate (CAGR), from $1.59M to $3.94M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.